Granules India rises on USFDA EIR with VAI classification
Granules India rises on USFDA EIR with VAI classification. Its subsidiary received an Establishment Inspection Report (EIR) from the USFDA with Voluntary Action Indicated (VAI) status post-inspection. This clears a key regulatory hurdle for exports to the US market. 📊 STOCKS: GRANULES | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #USFDA
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.